Low-Temperature Multiple Micro-Dispensing on Microneedles for Accurate Transcutaneous Smallpox Vaccination.
live virus
microneedle
smallpox vaccination
transcutaneous inoculation
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
04 Apr 2022
04 Apr 2022
Historique:
received:
28
02
2022
revised:
29
03
2022
accepted:
01
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
Smallpox is an acute contagious disease caused by the variola virus. According to WHO guidelines, the smallpox vaccine is administrated by scarification into the epidermis using a bifurcated needle moistened with a vaccine solution. However, this invasive vaccination method involving multiple skin punctures requires a special technique to inoculate, as well as a cold chain for storage and distribution of vaccine solutions containing a live virus. Here, we report a transcutaneous smallpox vaccination using a live vaccinia-coated microneedle (MN) patch prepared by a low-temperature multiple nanoliter-level dispensing system, enabling accurate transdermal delivery of live vaccines and maintenance of bioactivity. The live vaccinia in hyaluronic acid (HA) solutions was selectively coated on the solid MN tips, and the coating amount of the vaccine was precisely controlled through a programmed multiple dispensing process with high accuracy under low temperature conditions (2-8 °C) for smallpox vaccination. Inoculation of mice (BALB/C mouse) with the MN patch coated with the second-generation smallpox vaccine increased the neutralizing antibody titer and T cell immune response. Interestingly, the live vaccine-coated MN patch maintained viral titers at -20 °C for 4 weeks and elevated temperature (37 °C) for 1 week, highlighting improved storage stability of the live virus formulated into coated MN patches. This coated MN platform using contact dispensing technique provides a simple and effective method for smallpox vaccination.
Identifiants
pubmed: 35455310
pii: vaccines10040561
doi: 10.3390/vaccines10040561
pmc: PMC9024753
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Korea Health Industry Development Institute
ID : HV20C0078
Pays : Republic of Korea
Organisme : National Institute of Health in Korea
ID : 2020-NI-017-00
Références
Emerg Infect Dis. 1999 Jul-Aug;5(4):537-9
pubmed: 10458961
Dermatol Clin. 2004 Jul;22(3):263-74, vi
pubmed: 15207308
J Control Release. 2017 Nov 10;265:2-13
pubmed: 28286315
Arch Dermatol Res (1975). 1976 Jul 26;256(1):23-31
pubmed: 183611
Int J Pharm. 2011 Aug 30;415(1-2):140-9
pubmed: 21664444
Clin Cosmet Investig Dermatol. 2018 May 01;11:231-238
pubmed: 29750049
Drug Deliv Transl Res. 2019 Feb;9(1):192-203
pubmed: 30542944
J Virol. 2014 Jul;88(14):7753-63
pubmed: 24760885
Curr Top Microbiol Immunol. 2009;333:369-93
pubmed: 19768415
Drug Deliv. 2018 Nov;25(1):766-772
pubmed: 29536778
Pharm Res. 2012 Jan;29(1):170-7
pubmed: 21735335
Vaccine. 2007 Aug 14;25(33):6287-91
pubmed: 17597266
Clin Infect Dis. 2003 Jul 15;37(2):251-71
pubmed: 12856218
Science. 2002 Nov 15;298(5597):1428-32
pubmed: 12434061
N Engl J Med. 2002 Apr 25;346(17):1300-8
pubmed: 11923491
J Pharm Sci. 2011 Jun;100(6):2020-53
pubmed: 21337544
Vaccine. 2021 Aug 23;39(36):5214-5223
pubmed: 34334254
J Control Release. 2012 Jul 20;161(2):645-55
pubmed: 22342643
Vaccine. 2005 Mar 18;23(17-18):2078-81
pubmed: 15755574
Lancet. 2007 Dec 1;370(9602):1847-53
pubmed: 18061060
Microbiol Rev. 1983 Dec;47(4):455-509
pubmed: 6319980
Nat Med. 2010 Aug;16(8):915-20
pubmed: 20639891
Vaccine. 2002 May 15;20(16):2140-9
pubmed: 11972983
Bull World Health Organ. 1969;41(6):749-60
pubmed: 4985446
Vaccine. 2017 Jul 5;35(31):3889-3896
pubmed: 28606813
Nat Med. 2003 Sep;9(9):1125-30
pubmed: 12925845
Pharm Res. 2010 Feb;27(2):303-13
pubmed: 20013035
Polymers (Basel). 2020 Aug 11;12(8):
pubmed: 32796708
Adv Drug Deliv Rev. 2012 Nov;64(14):1547-68
pubmed: 22575858
Biomed Microdevices. 2017 Mar;19(1):2
pubmed: 28070698
Pharmaceutics. 2021 Feb 03;13(2):
pubmed: 33546332
Vaccine. 2011 Mar 21;29(14):2626-36
pubmed: 21277407
Int J Pharm. 2015 Oct 30;494(2):593-602
pubmed: 25617676
Spectrochim Acta A Mol Biomol Spectrosc. 2014;121:147-51
pubmed: 24239710
Am J Health Syst Pharm. 2003 Apr 15;60(8):749-56; quiz 757-8
pubmed: 12749161
Vaccine. 2013 Jul 25;31(34):3403-9
pubmed: 23044406
Vaccine. 2017 Apr 19;35(17):2115-2120
pubmed: 28364918
Hum Vaccin Immunother. 2016 Nov;12(11):2975-2983
pubmed: 27050528
JAMA. 1999 Jun 9;281(22):2127-37
pubmed: 10367824
AAOHN J. 2010 Aug;58(8):337-4; quiz 345-6
pubmed: 20704122
J Lab Clin Med. 2003 Oct;142(4):252-7
pubmed: 14625531
Clin Exp Vaccine Res. 2014 Jan;3(1):42-9
pubmed: 24427762
Nature. 2003 Oct 16;425(6959):681-5
pubmed: 14562094
Micromachines (Basel). 2021 Apr 14;12(4):
pubmed: 33919925
Vaccine. 2005 May 9;23(25):3301-9
pubmed: 15837236
J Control Release. 2018 Sep 28;286:460-466
pubmed: 30102940
Int J Infect Dis. 2004 Oct;8 Suppl 2:S31-44
pubmed: 15491873
J Control Release. 2013 Mar 10;166(2):159-71
pubmed: 23246470
Bull World Health Organ. 1969;41(6):771-8
pubmed: 5309530
Sci Rep. 2019 May 21;9(1):7631
pubmed: 31113974
Int J Infect Dis. 2007 Mar;11(2):98-108
pubmed: 16899385
PLoS One. 2018 Apr 13;13(4):e0195897
pubmed: 29652929
Nat Med. 2010 Feb;16(2):224-7
pubmed: 20081864
Chem Rev. 2020 Mar 25;120(6):3210-3229
pubmed: 31804810
J Pharmacol Exp Ther. 2019 Sep;370(3):555-569
pubmed: 31175217
Lancet. 2006 Feb 4;367(9508):425-35
pubmed: 16458769
Nat Biomed Eng. 2021 Sep;5(9):998-1007
pubmed: 33230304